PATENT CLAIM ANALYSIS

Application Number: 15928957
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["424", "444000"]

Abstract:
The present invention relates to a pharmaceutical dosage form for transmucosal delivery of an active agent to two or more mucosal surfaces. The dosage form is presented as a transmucosal delivery device. The devices of the invention may include at least two mucoadhesive surfaces. The devices may further include an intermediate layer disposed between the mucoadhesive layers. The pharmaceutical can be incorporated in any one or all of the mucoadhesive layers or the intermediate layer. Upon application, the device adheres to at least two surfaces, providing transmucosal delivery of the drug to at least two surfaces.

Claim (Index 35):
The method of  claim 33 , wherein T max  is less than about 80 minutes.

Metadata:
- Claim Count in Document: 57.0
- Percentile: 90.0
- Lexical Diversity: 2.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11639408', '13184306', '15198961', '15212912', '15135794']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7148401841077424
- 35 USC 102 Novelty (BERT): 0.5321657664026892
- Combined Prediction Score: 0.6965727423372371
- Mean Citation Score: 268.98602
- Max Citation Score: 287.26657
- Similarity Product: 147.43781864775897

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test